TsGRM Genetiko PAO

TsGRM Genetiko PAO EBIT

The EBIT of TsGRM Genetiko PAO (GECO.ME) as of Nov 1, 2026 is 25.90 M RUB. In the previous year, EBIT was -9.45 M RUB — a change of -373.98% (higher).

EBIT

25.90 MRUB

YoY

-373.98%

Last updated:

In 2024, TsGRM Genetiko PAO's EBIT was 25.90 M RUB, a -373.98% increase from the -9.45 M RUB EBIT recorded in the previous year.

The TsGRM Genetiko PAO EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT
Date
EBIT
Jan 1, 2022
-46.98 M RUB
Jan 1, 2023
-9.45 M RUB
Jan 1, 2024
25.90 M RUB
The TsGRM Genetiko PAO EBIT history
YEAREBITYoY
25.90 MRUB-373.98%
-9.45 MRUB-79.88%
-46.98 MRUB—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

TsGRM Genetiko PAO Revenue

TsGRM Genetiko PAO Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2022
312.60 M RUB
-46.98 M RUB
-77.97 M RUB
Jan 1, 2023
346.10 M RUB
-9.45 M RUB
-35.17 M RUB
Jan 1, 2024
425.96 M RUB
25.90 M RUB
-13.29 M RUB

TsGRM Genetiko PAO Margins

TsGRM Genetiko PAO stock margins

The TsGRM Genetiko PAO margin analysis displays the gross margin, EBIT margin, as well as the profit margin of TsGRM Genetiko PAO. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for TsGRM Genetiko PAO.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2022
15.15 %
-15.03 %
-24.94 %
Jan 1, 2023
23.91 %
-2.73 %
-10.16 %
Jan 1, 2024
26.58 %
6.08 %
-3.12 %

TsGRM Genetiko PAO Stock analysis

What does TsGRM Genetiko PAO do? TsGRM Genetiko PAO generates revenue through medical genetic services provided to doctors and patients via its four specialized laboratories. The company offers complex genetic diagnostics for hereditary diseases and reproductive disorders through its Next-Generation Sequencing (NGS) laboratory, Non-Invasive Prenatal Testing (NIPT) laboratory, Oncogenetics laboratory, and Genotyping laboratory. These services are delivered to healthcare professionals and individuals seeking genetic analysis. The firm's laboratory and production complexes form the core of its service delivery model, focusing on diagnostic solutions for medical genetics. TsGRM Genetiko PAO's primary customers are doctors who order genetic tests for their patients and patients directly seeking genetic diagnostics. The company's services include hereditary disease diagnostics and reproductive disorder assessments, which are conducted in its dedicated laboratory facilities. The firm's business model centers on providing specialized genetic testing services through its internal laboratory infrastructure without external partnerships or additional product lines. The company operates exclusively within the medical genetic services sector, delivering diagnostic solutions through its four laboratory divisions. Revenue is derived from the execution of genetic tests across all laboratory types, with no mention of additional product lines or external collaborations. The firm's structure is defined by its internal laboratory network, which serves both medical professionals and end patients. TsGRM Genetiko PAO is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing TsGRM Genetiko PAO's EBIT

TsGRM Genetiko PAO's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of TsGRM Genetiko PAO's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

TsGRM Genetiko PAO's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in TsGRM Genetiko PAO’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about TsGRM Genetiko PAO stock

EBIT of TsGRM Genetiko PAO is 25.90 M RUB in 2024.

EBIT of TsGRM Genetiko PAO changed from -9.45 M RUB to 25.90 M RUB, representing a -373.98% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT TsGRM Genetiko PAO since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's RUB is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's TsGRM Genetiko PAO historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — TsGRM Genetiko PAO

All Key Metrics — TsGRM Genetiko PAO